VoyForums
[ Show ]
Support VoyForums
[ Shrink ]
VoyForums Announcement: Programming and providing support for this service has been a labor of love since 1997. We are one of the few services online who values our users' privacy, and have never sold your information. We have even fought hard to defend your privacy in legal cases; however, we've done it with almost no financial support -- paying out of pocket to continue providing the service. Due to the issues imposed on us by advertisers, we also stopped hosting most ads on the forums many years ago. We hope you appreciate our efforts.

Show your support by donating any amount. (Note: We are still technically a for-profit company, so your contribution is not tax-deductible.) PayPal Acct: Feedback:

Donate to VoyForums (PayPal):

10/06/26 12:04:49Login ] [ Contact Forum Admin ] [ Main index ] [ Post a new message ] [ Search | Check update time | Archives: 1[2]34 ]
Subject: Re: Ilaug - Arnesen - Ilag - Vadheim


Author:
Lynwood (NYxepVjcaxMAsM)
[ Next Thread | Previous Thread | Next Message | Previous Message ]
Date Posted: 24/05/15 3:42:02
Author Host/IP: NoHost/188.143.232.37

Recorded Delivery <a rel=nofollow target=_blank href=" http://www.webdesignerslancaster.co.uk/joomla-website-optimisation.html ">adcirca therapy</a> Shares of nutritional ingredient and medical food makerEnzymotec rose as much as 25 percent in their marketdebut on Friday. The company's shares opened at $14.25 on theNasdaq and touched a high of $17.47. The Israel-based companyuses its technology to harvest lipids, which include fatty acidsand their derivatives, from natural sources and alters them tomake products that address human dietary needs, certaindisorders and common diseases.

[ Next Thread | Previous Thread | Next Message | Previous Message ]


[ Contact Forum Admin ]


Forum timezone: GMT-8
VF Version: 3.00b, ConfDB:
Before posting please read our privacy policy.
VoyForums(tm) is a Free Service from Voyager Info-Systems.
Copyright © 1998-2019 Voyager Info-Systems. All Rights Reserved.